Natural Endotech expecting favorable sales of phytoestrogen.

Published: 2006-03-14 06:55:00

Updated: 2006-03-14 06:55:00

Natural Endotech, a subsidiary of C&Tel, a Kosdaq listed home shopping company, reported on March 9 that this year sales of the phytoestrogen hormone and IGF-1 releasing stimulant remarkably would grow up.

Samsung Jeil hospital of Sunkyunkwan Univ. Medical School conducted a clinical test on p...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK